Stifel initiates Lyell Immunopharma stock with buy, $44 target
Stifel initiates Lyell Immunopharma stock with buy, $44 target
Stifel initiates Lyell Immunopharma stock with buy, $44 target
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.